Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Two Meropenem Formulations in Healthy Volunteers
NCT02344563Phase 4Completed
- Sponsor
- Yung Shin Pharmaceutical Industry
- Start
- Sep 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of meropenem in bacterial infection, sponsored by Yung Shin Pharmaceutical Industry. Started Sep 2014; status: completed.
02
Drugs
meropenem
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02344563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02344563.